RLDatix Life Sciences Blog
Video: Practical Strategies for Emerging, Small, and Mid-Size Companies
In the recently held Medicaid Drug Rebate Program (MDRP) Conference, a session titled Practical Strategies for Emerging, Small, and Mid-Size Companies offered essential insights for pharmaceutical companies navigating the complexities of expansion, commercialization, and mergers & acquisitions. The session, led by RLDatix Life Sciences’ Katie Johnson, Senior Director of Revenue… Read More
5 Ways iCoach Helps Coach Your Coaches
A top-performing life science sales organization relies on great coaching — not just for representatives but also to build top-notch coaching skills for sales leaders. Are you providing the resources to guide your coaches to success? Good sales managers can’t just settle for being great organizers or… Read More
Simplify Government Pricing Compliance with These 3 Essential Checklists
Government pricing compliance in the pharmaceutical industry can be overwhelming, with serious consequences for any missteps. To avoid costly penalties and ensure your company stays compliant, it’s essential to have a structured approach. That’s why we’ve created three valuable government pricing compliance checklists — monthly, quarterly, and… Read More
Streamline Government Pricing Compliance for Growth
Government pricing compliance in the pharmaceutical industry is one of the most complex and high-stakes areas of regulation. With the US government being the largest payer, especially through programs like Medicare and Medicaid, maintaining compliance is critical. But how well are you navigating this intricate landscape? A single… Read More
How to Tackle the Complexities of Multi-Jurisdictional Spend Transparency
Transparency is a critical pillar in the life sciences industry, especially when it comes to pharmaceutical companies and their interactions with healthcare professionals. But with so many regulations and complexities, maintaining transparency in multi-jurisdictional reporting can feel like an uphill battle. For Life Sciences companies, maintaining… Read More
Navigating the New CMS Medicaid Drug Rebate Final Rule: Key Updates
On September 20, 2024, the Centers for Medicare & Medicaid Services (CMS) made news in the life sciences industry with the release of a highly anticipated final rule, “Medicaid Program; Misclassification of Drugs, Program Integrity Updates Under the Medicaid Drug Rebate Program.” This update has brought significant clarity to our… Read More
What to Do After Receiving a CMS Open Payments Program Letter: Common Questions
If your organization has products listed in the Medicare Part D Formulary, you may have received a notification from the Centers for Medicare & Medicaid Services (CMS) about additional reporting requirements under the Open Payments Program. These Open Payments Program letters may leave you wondering: Are we meeting all… Read More
Optimizing Digital Transformation in Life Sciences: Essential Strategies for Success
Digital transformation is reshaping the way Life Sciences companies drive revenue, maintain compliance, and navigate the intricate web of global regulations. It’s not just about upgrading technology—it’s about embracing a new mindset and strategic approach to operations, which can determine the success or failure of a company in this highly… Read More
The Biggest Challenges in HCP Interactions and How to Overcome Them
In the Life Sciences industry, maintaining high ethical standards in interactions with healthcare providers and organizations (HCPs and HCOs) is crucial. These relationships are heavily regulated to prevent conflicts of interest and ensure that medical decisions are based on the best interests of patients, not commercial influences. In the United… Read More